Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study.
about
GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational ProspectiveCardiac target organ damage in hypertension: insights from epidemiologyGDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in menClinical and genetic correlates of growth differentiation factor 15 in the communityThe novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction.Biomarkers of coronary artery disease: the promise of the transcriptome.Emerging biomarkers in heart failure and cardiac cachexiaGrowth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study.Biomarkers of cardiovascular stress and subclinical atherosclerosis in the community.Inflammation and cardiac outcomeAssociations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident StrokeGrowth-differentiation factor-15 and functional outcome after acute ischemic stroke.Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major BleedingThe use of a cytokine panel to define the long-term risk stratification of heart failure/death in patients presenting with chest pain to the emergency department.Effect of Atorvastatin on Growth Differentiation Factor-15 in Patients with Type 2 Diabetes Mellitus and Dyslipidemia.TGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulatorGDF 15--A Novel Biomarker in the Offing for Heart Failure.Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.Plasma levels of growth differentiation factor-15 are associated with myocardial injury in patients undergoing off-pump coronary artery bypass grafting.Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic trainingRelations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: The Framingham Heart Study.Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening.Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome.Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study.GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery diseaseGrowth differentiation factor (GDF)-15 blocks norepinephrine-induced myocardial hypertrophy via a novel pathway involving inhibition of epidermal growth factor receptor transactivation.Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside.Growth differentiation factor 15 in heart failure: an update.Heart failure biomarkers.Evaluation factors of pulmonary embolism severity and prognosis.Circulating biomarkers in patients with heart failure and preserved ejection fraction.Gliptin therapy reduces hepatic and myocardial fat in type 2 diabetic patients Gliptins and cardiometabolic risk.GDF-15 predicts cardiovascular events in acute chest pain patients.Association of Growth Differentiation Factor 15 with Mortality in a Prospective Hemodialysis Cohort.Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders.Growth differentiation factor-15 (GDF-15) suppresses in vitro angiogenesis through a novel interaction with connective tissue growth factor (CCN2).Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension.The TGF-β superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism.Growth differentiation factor-15: a new biomarker in cardiovascular disease.Novel plasma and imaging biomarkers in heart failure with preserved ejection fraction.
P2860
Q26798142-17DE8011-7C5C-4186-A6DD-EC00CB916D85Q27007701-032AA8B5-FE92-436C-AF2E-1DFE1E0B225EQ28535575-6FFFF7B7-AD47-4D5B-93E4-41A07795C8C8Q34114806-F25B4C03-40A4-4B93-ACBE-734983375C58Q34343385-9E7A9EB9-04EA-48AC-A76D-77C0A1AA4B64Q34507146-2BA9E707-75DF-4C19-ABEE-BCEEFC3A6C50Q34836097-17EB9E13-701C-4100-9317-FA456C882F9AQ35021094-B4D8C5FE-B9EF-4F72-BE30-51C4BC6F05B4Q35224090-90C40B6D-B546-4354-9DD9-C42F6C3E8AD5Q35835539-DCD86415-A0E1-4ED5-B60A-D083ABBEECD2Q35998337-42365E88-0928-47EE-BE4C-EFAFEF88A073Q36133676-1BF8AFF9-36D9-4E07-A997-7F1BA741C664Q36347479-561C97B7-41CF-4F71-B55F-256F20D9B42AQ36601675-D86C762E-3781-483A-9F73-54106DA88E6FQ36621007-098F3CD6-6F03-42C7-94B5-EF4003B3DAB6Q36647686-3B77FB25-9297-4557-AF7C-582651A313CEQ36728674-8C387FA2-0E96-48D8-B168-0BED170C8265Q36851584-05B565A0-A477-4A18-A595-E17EE4F340CFQ37014872-04075E25-6EDB-4B0C-9FE2-9CBD735D9B96Q37213203-659B8E8F-808C-4182-8621-D838997AC9D7Q37246297-372025DD-AD73-4892-AD12-684FC1D4F493Q37457712-DB884725-9650-4A62-BB2F-EC966FD7B1E0Q37463255-CF26C16A-B64A-4716-BC88-BFFC2AF76A1EQ37588805-715CE37C-3A1A-4074-9630-EBF495508E1AQ37673443-D1F1612C-B894-4AB4-A2E2-6ABA56CA6120Q37683299-A151300A-C4E0-4031-B137-1A3199026D97Q37896086-6403E8DB-F02E-4AFE-8CB8-8AA215720FA0Q38041973-3A02974D-28B6-4217-A752-E5F9E4603560Q38100647-C3732115-AB5D-469D-84E9-7AAA74005F65Q38136163-A234FDC7-53F1-44A1-81DB-66C95F34E727Q38152289-E6F90F43-9A83-4EBB-BBC5-B02928F52E47Q38620945-69984C52-E4C6-45DC-9ECC-4361321E55C3Q38647581-259DDD5E-E879-447B-B45E-D5C1FED7977CQ38671285-8B51DA2E-5875-41F0-B40F-B7BA1A80703FQ38790569-48EB0ED0-53E0-4F47-B2DA-F5DA10F84AA4Q39218029-CDBBC677-197B-4F6A-BF5C-D6027B0357FEQ39297265-82759687-269B-431F-9F14-4817821507B5Q39492314-94B9E3CC-AB94-49B5-B3AE-27D3070DC49AQ39917432-528BC6B5-DBB3-49AD-80DB-06A82A857B8CQ40963394-20B12F0E-29A6-4DD9-9663-C759B9A26972
P2860
Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Growth-differentiation factor- ...... Uppsala Seniors (PIVUS) Study.
@en
Growth-differentiation factor- ...... Vasculature in Uppsala Seniors
@nl
type
label
Growth-differentiation factor- ...... Uppsala Seniors (PIVUS) Study.
@en
Growth-differentiation factor- ...... Vasculature in Uppsala Seniors
@nl
prefLabel
Growth-differentiation factor- ...... Uppsala Seniors (PIVUS) Study.
@en
Growth-differentiation factor- ...... Vasculature in Uppsala Seniors
@nl
P2093
P2860
P50
P356
P1476
Growth-differentiation factor- ...... Uppsala Seniors (PIVUS) Study.
@en
P2093
Anders Elmgren
Anja Quint
Bertil Lindahl
Heike Tapken
Johannes Hulthe
Kai C Wollert
Sylvia Olofsson
Tibor Kempf
P2860
P304
P356
10.1093/EURHEARTJ/EHP261
P577
2009-06-26T00:00:00Z